Screening and diagnosis

Classification and risk stratification

Perioperative care

Quality improvement

Patient education

Nonpharmacologic interventions

Therapeutic procedures

Respiratory support

Follow-up and surveillance

Specific circumstances

Preventative measures

Medical management

Surgical interventions

Inpatient care

Diagnostic procedures

Diagnostic investigations

Insufficient evidence to make a recommendation.

Strongly favor this test or intervention.

The Gurd and Wilson criteria calculator is designed to determine the likelihood of fat embolism syndrome in a patient by evaluating five specific health indicators. Each of these criteria contributes a numerical score of 1 if present. The criteria assessed are:

- Age over 65 years
- Renal insufficiency with a peak stabilized creatinine level of 150 micromoles per liter (mcmol/L) or higher
- Cardiac insufficiency
- Gastrointestinal (GI) involvement
- Absence of ear, nose, and throat (ENT) manifestations

For each condition that is true, the calculator assigns a score of 1. Therefore, the total score is the sum of the individual scores from these criteria and can range from 0 to 5.

Interpretation of the score is as follows:
- A total score between 0 and 13 indicates that the criteria for fat embolism syndrome are not met.
- A score of 14 or greater suggests that the criteria may be met, although given the scoring method, the actual scores should be between 0 and 5. However, this part appears inconsistent within the provided logic since such scores are not possible. In practical terms, any positive score could imply a potential symptom match, but a full medical evaluation is necessary.

The Gurd and Wilson criteria is a clinical calculator used for diagnosing Fat Embolism Syndrome (FES). This scoring system is applicable to patients who have experienced long bone fractures, orthopedic surgeries, or severe burns, as these are common situations where fat embolism can occur. 

The Gurd and Wilson criteria for FES is a diagnostic tool that helps clinicians identify the presence of this syndrome based on a combination of major and minor criteria. Major criteria include respiratory insufficiency, cerebral involvement, and petechial rash. Minor criteria include tachycardia, fever, retinal changes, jaundice, renal changes, and others. 

The clinical utility of this calculator is to aid in the early diagnosis of FES, which can be life-threatening if not treated promptly. It helps to differentiate FES from other conditions with similar symptoms, such as pneumonia or stroke. 

There are no specific exclusion criteria for the use of the Gurd and Wilson criteria. However, it should be noted that this scoring system is not definitive and should be used in conjunction with other clinical findings and diagnostic tests.

Gurd and Wilson criteria for fat embolism syndrome

The Schonfeld's criteria calculator for fat embolism syndrome takes user input related to six clinical signs and symptoms, evaluating their presence as boolean (true/false) values. Each positive symptom is assigned a numerical score based on a predefined scale, and these scores are summed to determine if the diagnostic criteria are met.

The following scoring system is used:

| Symptom                                                | Score |
|--------------------------------------------------------|-------|
| Petechiae                                               | 5     |
| Diffuse alveolar infiltrates on chest X-ray             | 4     |
| Arterial partial pressure of oxygen < 70 mmHg           | 3     |
| Fever > 38 degrees C                                    | 1     |
| Heart rate > 120 bpm                                    | 1     |
| Respiration rate > 30 bpm                               | 1     |

For each symptom, if a user marks it as true, the corresponding score is added to the total score. The total score, ranging from 0 to 15, helps determine whether the diagnostic criteria for fat embolism syndrome are met.

The interpretation of the total score is as follows: If the total score is greater than or equal to 5, the interpretation is "Diagnostic criteria are met," indicating a likelihood of fat embolism syndrome. If the total score is less than 5, the interpretation is "Diagnostic criteria are not met," suggesting that fat embolism syndrome is unlikely based on these criteria.

Schonfeld's criteria for fat embolism syndrome is a diagnostic tool designed to identify patients at risk of developing this potentially life-threatening complication. The target patient population includes those who have experienced trauma or surgical procedures, particularly those involving long bones or the pelvis, where fat emboli may enter the bloodstream.

The primary components of Schonfeld's criteria include the presence of petechiae, diffuse alveolar infiltrates on chest X-ray, arterial partial pressure of oxygen less than 70 mmHg, fever greater than 38 degrees Celsius, heart rate exceeding 120 beats per minute, and respiration rate over 30 breaths per minute. Each of these components contributes to the overall score, which aids in the diagnosis of fat embolism syndrome.

Schonfeld's criteria for fat embolism syndrome

The DIRE score calculator helps determine a patient's suitability for long-term opioid analgesia by assessing various aspects of their pain management and personal circumstances. This evaluation takes into account the following factors:

- Diagnosis: The nature and severity of the patient's medical condition.
- Intractability: The extent of treatments tried and the patient's engagement in their pain management.
- Psychological Risk: The impact of mental health on the patient's ability to undergo treatment.
- Chemical Health Risk: The patient's history or current use of substances.
- Reliability Risk: The patient's consistency in adhering to treatment plans.
- Social Support Risk: The stability of the patient's social environment and support system.
- Efficacy: The effectiveness of opioid treatment in improving pain and function.

Each factor is scored on a scale from 1 to 3. For Diagnosis, for example, a benign condition earns a 1, while an advanced condition earns a 3. This scoring continues through each factor:

- Intractability ranges from minimal effort in managing pain (1) to full engagement but inadequate response (3).
- Psychological Risk evaluates serious personality dysfunctions (1) to good communication and no significant psychological issues (3).
- Chemical Health Risk considers active substance abuse (1) to no history of chemical dependence (3).
- Reliability Risk scores numerous compliance issues (1) to high reliability (3).
- Social Support Risk ranges from chaotic lifestyle (1) to strong supportive relationships (3).
- Efficacy varies from poor function despite treatment (1) to considerable improvement and stable dosing (3).

The scores from each category are added together, resulting in a total score between 7 and 21. This total informs the interpretation:

- If the total score is 13 or less, the patient is deemed not suitable for long-term opioid analgesia.
- A total of 14 or more suggests the patient is a good candidate for such treatment.

This comprehensive scoring approach ensures that decisions related to opioid therapy are made with careful consideration of both potential benefits and risks.

The DIRE Score, or Diagnosis, Intractability, Risk, and Efficacy Score, is a clinical calculator used in the management of chronic pain patients who are being considered for long-term opioid therapy. This scoring system is designed to assess the patient's risk of opioid misuse and to determine the appropriateness of opioid prescription. 

The DIRE Score applies to adult patients with chronic non-cancer pain who are being evaluated for long-term opioid therapy. It is particularly useful in stratifying patients based on their risk of opioid misuse, thus aiding clinicians in making informed decisions about opioid prescription. 

The DIRE Score considers four main factors: Diagnosis (the nature and extent of the patient's pain condition), Intractability (the degree to which the pain is resistant to treatment), Risk (the patient's risk of opioid misuse or addiction), and Efficacy (the likelihood that opioid therapy will be effective for the patient's pain). 

There are no specific exclusion criteria for the use of the DIRE Score, but it should be noted that it is not intended for use in patients with cancer-related pain or in those who are already on long-term opioid therapy. It is also not a substitute for a comprehensive clinical assessment and should be used in conjunction with other clinical tools and

Hip osteoarthritis

Guidelines

Key sources

Medical management

Nonpharmacologic interventions

Therapeutic procedures

Perioperative care

Surgical interventions